Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma
Open Access
- 11 July 2015
- journal article
- research article
- Published by Springer Nature in Diagnostic Pathology
- Vol. 10 (1) , 1-7
Abstract
The CC chemokine receptor 9 (CCR9) plays an important role in tumorigenesis and metastasis in various cancers. Our previous studies have shown the aberrant expression of CCR9 in non-small cell lung cancer (NSCLC) cell lines, revealing that the CCR9-CCL25 axis modulates cell migration and invasion, and supports cancer cell survival by inhibiting apoptosis in vitro and in vivo. In the present study, we aimed to evaluate the expression and possible prognostic role of CCR9 in lung adenocarcinoma. Immunohistochemical analysis of CCR9 expression was performed on 144 lung adenocarcinoma tissues and 30 adjacent normal lung parenchymal tissues. We assessed the correlation of CCR9 expression with clinicopathological characteristics and the prognosis of lung adenocarcinoma. The expression of CCR9 was increased in lung adenocarcinoma tissue compared with normal lung tissue. Moreover, such an expression was positively correlated with tumor size (p = 0.032), lymph node metastasis (p = 0.002) and advanced TNM stage (p = 0.012). In addition, the patients with negative CCR9 expression exhibited a higher overall survival (OS) compared with those with positive CCR9 expression. Multivariate analysis showed that the CCR9 expression was an independent prognostic factor for the OS of patients with lung adenocarcinoma. We, for the first time, reported that CCR9 could be beneficial in predicting lymph node metastasis, and it might act as a novel prognostic biomarker for lung adenocarcinoma.Keywords
Funding Information
- Scientific Research and Technological Development Projects of Guangxi Zhuang Autonomous Region, P R China (No.14144004)
- The Appropriate Technology Research and Development Project of Health Department, Guangxi Zhuang Autonomous Region, P R China (No.S201313-02)
This publication has 29 references indexed in Scilit:
- Chemokine 25–induced signaling suppresses colon cancer invasion and metastasisJournal of Clinical Investigation, 2012
- The 7th lung cancer TNM classification and staging system: Review of the changes and implicationsWorld Journal of Radiology, 2012
- CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashionWorld Journal of Surgical Oncology, 2011
- CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashionInternational Journal of Oncology, 2011
- Human IgG inhibits IgA1 protease-dependent adherence of Haemophilus influenza strains to human lung epithelial cellsAsian Biomedicine, 2011
- CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasionWorld Journal of Surgical Oncology, 2010
- CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashionJournal of Ovarian Research, 2010
- Involvement of a Novel Chemokine Decoy Receptor CCX-CKR in Breast Cancer Growth, Metastasis and Patient SurvivalClinical Cancer Research, 2009
- Expression and Functional Role of CCR9 in Prostate Cancer Cell Migration and InvasionClinical Cancer Research, 2004
- Functional CCR9 Expression Is Associated with Small Intestinal MetastasisJournal of Investigative Dermatology, 2004